Back to VA VANGUARD CAPITAL MANAGEMENT LLC
KRYS2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in Krystal Biotech, Inc.
VANGUARD CAPITAL MANAGEMENT LLC holds 1.2M shares of KRYS (Krystal Biotech, Inc.), worth $461.1M as of 2026-Q2. The position was increased (+6.5% shares). KRYS represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$461.1M
Current Shares
1.2M
Total Value Change
+$160.1M
Total Shares Change
+75,243
Quarter-by-Quarter History
Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC